IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Richard Belanger who wrote (1706)	5/26/2000 6:30:00 AM
From: Maurice Winn	1 Recommendation Read Replies (1) of 1762

Gidday and thanks for that Rich and also to BobL for the Zevalin results. The medical industry does NOT move on internet time. The difference between the two is about as wide as it could get. A common cliche is 'human life is invaluable' meaning human life is worth a lot. Well, if we judge by leisurely actions rather than words, we can't really say that's true. Rituxan has been available for 2 and a half years. Zevalin is grinding ever so slowly through the linear regression analyses and FDA hoop-jumping procedures excruciatingly slowly. All grist to the highly-paid guild members of course. Yet oncologists seem still to be 'discovering' Rituxan with the % of patients being treated continuing to increase. I understand Rituxan is STILL not used in New Zealand. That's apparently because our 'free' medical system means it would be unethical to treat somebody in one bed who pays but not another in the next bed who clinically needs the treatment too but is impecunious. It is apparently more ethical to have everybody die evenly than to allow treatment to those who can afford it and thereby save at least some people. The budgets are not available for such plush treatment as Rituxan which gives benefits not deemed to be sufficient to justify the cost. Which of course puts a quite pragmatic and relatively low value on human life. Oncolym which attacks antigens other than CD20 could be used in conjunction with Rituxan and of course Zevalin and probably CHOP to do a better job of ensuring every last lymphoma cell is destroyed in the early days when total destruction has a better chance. All like a blunderbuss, but better than nothing or earlier treatments such as CHOP and external beam radiation. I suppose in another 5 years they'll be getting around to that. My two year old formulation seems to be the direction things are going. I should have patented it! The cod liver oil with the Vitamin D, A and omega-3 fatty acids are the key! No, I haven't done clinical trials. Meanwhile, Zevalin seems a much better idea than Rituxan, so it's a puzzle that oncologists are happy to keep messing about with Rituxan when Zevalin seems a real method of dealing with lymphoma cells. I suppose it's illegal for people to be treated with Zevalin until it's FDA rubber-stamped. I wonder if any people will die who could be saved or have their lives extended if they get permission to use Zevalin. I wonder if any of them will resent dying when they might live with Zevalin treatment. All very puzzling. Maurice

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next